Background illustration for clinical trials search

Paid Clinical Trials Memphis

Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Memphis TN, St Louis MO, Kansas City KS, Dallas TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07358078

Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Bartlett TN, Mount Juliet TN, Tennessee City TN,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Memphis TN, Nashville TN, Lexington KY, Dallas TX,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Memphis TN, Southaven MS, Germantown TN, Bartlett TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

for
Lymphoid Malignancies
Location: Memphis TN, Louisville KY, Dallas TX, Chicago IL,
Sponsor: AVM Biotechnology Inc

Sex: All

Age: 12 - 70+

Code: NCT04329728

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

for
Cancer Weight Loss
Location: Memphis TN, Atlanta GA, Oklahoma City OK, Wichita KS,
Sponsor: Endevica Bio

Sex: All

Age: 18+

Code: NCT06937177

Phase2, Recruiting

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

for
Cardiovascular Diseases, Heart Diseases, Heart Failure
Location: Memphis TN, Little Rock AR, Birmingham AL, St Louis MO,
Sponsor: BrioHealth Solutions, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06310031

Recruiting

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
Location: Memphis TN, Germantown TN, Huntsville AL, St Louis MO,
Sponsor: University of British Columbia

Sex: All

Age: 0+

Code: NCT04634240

Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Southaven MS, Birmingham AL, Weldon Spring MO,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: Memphis TN, St Louis MO, Athens GA, Dallas TX,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT03093116

Phase1, Phase2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Memphis TN, Germantown TN, Nashville TN, Jackson MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Memphis TN, Nashville TN, Indianapolis IN, Iowa City IA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase1, Phase2, Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: Memphis TN, Louisville KY, Knoxville TN, Cincinnati OH,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT04614103

Phase2, Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Memphis TN, Carterville IL, Birmingham AL,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

Immunonutrition in Ulcerative Colitis

for
Ulcerative Colitis
Location: Memphis TN
Sponsor: Baptist Memorial Health Care Corporation

Sex: All

Age: 18+

Code: NCT03594708

Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Memphis TN, Birmingham AL, Atlanta GA, Kansas City KS,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

Temsirolimus as Second-line Therapy in HCC

for
Unresectable or Metastatic Hepatocellular Carcinoma
Location: Memphis TN
Sponsor: University of Tennessee Cancer Institute

Sex: All

Age: 18+

Code: NCT01567930

Phase2, Recruiting

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

for
Non-small Cell Lung Cancer
Location: Memphis TN, Nashville TN, Chattanooga TN, Louisville KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06077760

Phase3, Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

for
Small Cell Lung Cancer
Location: Memphis TN, Zion IL, Tampa FL, Saint Paul MN,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07531095

Phase1, Recruiting

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

for
Extensive Stage Small Cell Lung Cancer
Location: Memphis TN, St Louis MO, Louisville KY, Atlanta GA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037758

Phase1, Recruiting